Vermeire S, Lakatos PL, Ritter T, Hanauer S, et al. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. Lancet Gastroenterol Hepatol 2021 Nov 16. pii: S2468-1253(21)00295.
PMID: 34798037